Relistor
1 known investors
RELISTOR is a prescription medication containing methylnaltrexone bromide that treats opioid-induced constipation in adults with chronic pain or advanced illness. The drug is available in tablet and injection forms and is marketed for patients requiring pain management with opioids.
Investors · 1
Frequently asked questions
- What does Relistor do?
- RELISTOR is a prescription medication containing methylnaltrexone bromide that treats opioid-induced constipation in adults with chronic pain or advanced illness. The drug is available in tablet and injection forms and is marketed for patients requiring pain management with opioids.
- Who are Relistor's investors?
- Relistor's investors include HEALTHCARE ROYALTY PARTNERS.